Improving Health Literacy in African-American Prostate Cancer Patients
This trial studies how well an educational interview works in improving health literacy in African-American participants with prostate cancer. An educational interview may help participants understand prostate cancer treatment and side effects better.
I. Characterize health literacy in a group of newly diagnosed, early stage, African American prostate cancer patients across five empirical domains including 1) reading skills, 2) simple mathematical skills for risk communication (the ability to calculate a simple fraction or a percent), 3) anatomic knowledge, 4) comprehension of common medical terms used in prostate cancer, 5) cancer biology and prostate cancer knowledge.
II. Assess comprehension of prostate cancer treatment options and side effects in this group of patients after they meet with their urologist to discuss their treatment alternatives (standard practice).
III. Deliver a scripted, low literacy educational supplement that explicitly addresses each domain of health literacy to tailor content and augment the information that patients receive from their urologists.
IV. Compare outcomes after patients meet with their urologist and after receiving the low literacy supplement to quantify the potential benefit of a targeted health literacy supplement over and above standard practice.
V. Compare urologists’ assessment of patients’ 1) health literacy 2) preferences for side effects, 3) stage of decision making, 4) treatment choice or predisposition toward treatment choice, 5) preference for role in decision making; to measures obtained from patients.
Participants attend a face to face interview over 45-60 minutes consisting of a scripted educational supplement regarding prostate cancer treatment options and side effects.
After completion of study, participants are followed up prior to prostate cancer treatment.
Treatment Sites in Georgia
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials